All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
R B Barnes, R A Lob. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation. The Journal of clinical endocrinology and metabolism. vol 61. issue 4. 1985-10-09. PMID:3928677. we conclude that 1) brain or central opioid activity is not decreased in pco; 2) increased central opioid activity does not appear to be responsible for the increased lh levels characteristic of the syndrome; and 3) decreased central dopamine activity and/or the interaction between the dopaminergic and opioid systems may be altered in pco. 1985-10-09 2023-08-11 Not clear
J N Joyce, S K Loeschen, J F Marshal. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain research. vol 338. issue 2. 1985-10-01. PMID:3161583. dopamine d-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. 1985-10-01 2023-08-11 rat
J N Joyce, S K Loeschen, J F Marshal. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain research. vol 338. issue 2. 1985-10-01. PMID:3161583. there were no lateral-to-medial differences in the dopaminergic innervation of the cpu, as determined by the measurement of the levels of dopamine, homovanillic acid and dihydroxyphenylacetic acid in subregions of the cpu using high pressure liquid chromatography. 1985-10-01 2023-08-11 rat
H Watanab. Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in mice. Journal of pharmacological methods. vol 14. issue 1. 1985-10-01. PMID:3928976. these results indicate that the estimation of striatal l-dopa from a single mouse brain is feasible, and dopamine receptor agonists, apomorphine, and ergot alkaloids have stimulatory effects on the activity of presynaptic dopamine receptors of the nigrostriatal dopaminergic neurons of the mouse. 1985-10-01 2023-08-11 mouse
A Closse, W Frick, R Markstein, R Maurer, R Nordman. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors. Journal of neural transmission. vol 62. issue 3-4. 1985-09-27. PMID:3161996. [3h]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine d2 receptors. 1985-09-27 2023-08-11 Not clear
A Closse, W Frick, R Markstein, R Maurer, R Nordman. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors. Journal of neural transmission. vol 62. issue 3-4. 1985-09-27. PMID:3161996. [3h]205-501, a noncatechol dopaminergic agonist, is presented as a ligand with high affinity (kd approximately 1 nm) and high selectivity for dopamine receptors. 1985-09-27 2023-08-11 Not clear
A Closse, W Frick, R Markstein, R Maurer, R Nordman. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors. Journal of neural transmission. vol 62. issue 3-4. 1985-09-27. PMID:3161996. pki values of dopaminergic agonists derived from competition isotherms in the [3h]205-501 binding assay correlate very well with their potency in the acetylcholine release assay, which is controlled by dopamine d2 receptors. 1985-09-27 2023-08-11 Not clear
J G Cannon, C Koble-Suarez, J P Long, M Ilhan, R K Bhatnaga. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines. Journal of pharmaceutical sciences. vol 74. issue 6. 1985-09-25. PMID:4040568. cis- and trans-4-n-propyloctahydrobenzo(f)quinolines 4a,b were prepared for further assessment of dopaminergic effects of non-oxygenated dopamine congeners. 1985-09-25 2023-08-11 rat
R Sommerville, H E Rosenberg, P A Crook. Synthesis and pharmacological evaluation of aromatic dihydroxylated spiro[indan-1,3'-pyrrolidine] and spiro[indan-2,2'-pyrrolidine] derivatives. Journal of pharmaceutical sciences. vol 74. issue 5. 1985-09-23. PMID:4020632. none of these conformationally restricted catecholamines possessed any dopaminergic activity, but 5,6-dihydroxy spiro[indan-1,3'-pyrrolidine] hydrobromide exhibited weak dopamine antagonist properties. 1985-09-23 2023-08-11 Not clear
M Rosolowsky, H R Weis. Effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium. Journal of cardiovascular pharmacology. vol 7. issue 4. 1985-09-19. PMID:2410711. effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium. 1985-09-19 2023-08-11 rabbit
M Rosolowsky, H R Weis. Effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium. Journal of cardiovascular pharmacology. vol 7. issue 4. 1985-09-19. PMID:2410711. dopamine, 10, 100, or 1,000 micrograms/kg/min, was infused in the presence of dopaminergic, beta-, or alpha-adrenergic receptor blockade. 1985-09-19 2023-08-11 rabbit
M Rosolowsky, H R Weis. Effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium. Journal of cardiovascular pharmacology. vol 7. issue 4. 1985-09-19. PMID:2410711. it can be concluded that direct or indirect vasodilator receptors (dopaminergic, beta 1-, and beta 2-adrenoceptors) must be stimulated and perfusion pressure must not fall in order for dopamine to produce increases of coronary blood flow within occluded myocardium. 1985-09-19 2023-08-11 rabbit
H Schoemaker, C Pimoule, S Arbilla, B Scatton, F Javoy-Agid, S Z Lange. Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Naunyn-Schmiedeberg's archives of pharmacology. vol 329. issue 3. 1985-09-19. PMID:3927176. sodium dependent [3h]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in parkinsons disease. 1985-09-19 2023-08-11 human
G R Breese, T C Napier, R A Muelle. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. The Journal of pharmacology and experimental therapeutics. vol 234. issue 2. 1985-09-17. PMID:3926987. these results indicate that d-1 dopamine receptors contribute to modulation of central dopaminergic function. 1985-09-17 2023-08-11 rat
H Fink, R Morgenster. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions. Psychopharmacology. vol 85. issue 4. 1985-09-12. PMID:2991961. it is concluded that the locomotor stimulant effect of higher doses of lisuride may depend on stimulation of postsynaptic dopamine receptors and a serotonergic action and that the locomotor effects of lisuride reflect a complex interaction at dopaminergic and serotonergic transmission systems. 1985-09-12 2023-08-11 rat
A R Artalejo, A G García, C Montiel, P Sánchez-Garcí. A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. The Journal of physiology. vol 362. 1985-09-12. PMID:4020691. the fact that dopamine is released in measurable amounts, together with adrenaline and noradrenaline, from perfused cat adrenal glands in response to nicotinic stimulation (v. ceña, unpublished results), favours a role for this dopaminergic receptor in modulating catecholamine release from the chromaffin cell. 1985-09-12 2023-08-11 cat
S Koyama, M Sasaki, T Setoyama, K Takahashi, K Togashi, K Suzuki, N Kakki, M Ima. Dopaminergic modulation of the renal effect of arginine-vasopressin in water-loaded rats. Japanese journal of pharmacology. vol 38. issue 1. 1985-09-11. PMID:4021228. these observations support the view that dopamine inhibits the antidiuretic action of vasopressin by dopaminergic receptors also in the mammalian kidney. 1985-09-11 2023-08-11 rat
S R George, M Watanabe, T Di Paolo, P Falardeau, F Labrie, P Seema. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology. vol 117. issue 2. 1985-08-29. PMID:4017954. in order to determine whether the high affinity state or the low affinity state of the dopamine receptor mediated the inhibition of release of prl by dopamine agonists, a large number of dopaminergic agonists (n = 31) and antagonists (n = 24) were tested for their potencies to inhibit the binding of [3h] spiperone to porcine anterior pituitary tissue, and for their potencies to affect the release of prl from rat anterior pituitary cells in culture. 1985-08-29 2023-08-11 rat
D G Kirch, M R Palmer, M Egan, R Freedma. Electrophysiological interactions between haloperidol and reduced haloperidol, and dopamine, norepinephrine and phencyclidine in rat brain. Neuropharmacology. vol 24. issue 5. 1985-08-26. PMID:2862598. phencyclidine, which is an indirect dopaminergic agonist in the caudate, caused inhibition of the discharges of caudate neurons resembling that induced by dopamine itself. 1985-08-26 2023-08-11 rat
J Barber, R Tomer, H Sroka, M S Myslobodsk. Does unilateral dopamine deficit contribute to depression? Psychiatry research. vol 15. issue 1. 1985-08-22. PMID:3859881. given that dopaminergic pathways are involved in affective behavior, depression, which is recognized as an integral part of parkinson's disease, may be associated with a dopamine imbalance. 1985-08-22 2023-08-11 Not clear